Dec 11, 2024 · By Arda Ural, Ph.D. Arda Ural, Ph.D. Key innovation, technology, dealmaking and policy considerations are reshaping the industry’s future. While patent expirations of $300b will continue to put pressure on growth, robust innovation likely will partially offset top-line erosion.

Life Science Leader - thought leadership articles and discussions about the current life science industry

Dec 23, 2024 · <p>Where are legislative trends pointing on biopharmaceutical patents? Sona De, a partner at Sidley, reviews existing proposals and offers thoughts on what&#39;s to come in 2025.</p>

Oct 4, 2024 · This article is part one of a two-part series. Part two is available here.. Part 1: AI for rapid Drug Discovery. In the rapidly evolving landscape of pharmaceutical development, AI promises to revolutionize the entire drug discovery and development process, impacting target discovery, clinical trial design, site selection, and even …

Dec 19, 2024 · <p>Local market pharmacovigilance (PV) requirements can be daunting to manage successfully. Experts at PharmaLex provide best practices for managing PV across local affiliates.</p>

Oct 28, 2024 · <p>Explore key drugs anticipated for 2025, spanning oncology, neurology, autoimmune disorders, and infectious diseases, with potential for significant market impact and new treatment paradigms.</p>

Oct 3, 2024 · <p>An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment and return. However, it won&#39;t work for every company, as Abbas Kazimi, chief business officer at Nimbus Therapeutics, explains.</p>

Oct 23, 2024 · <p>Part two of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI tools improve the probability of success and likelihood of drug approval.</p>

Sep 22, 2024 · By Ben Comer, Chief Editor, Life Science Leader. Steven Kelly. Then: In a 2021 “Companies To Watch” article written by Wayne Koberstein, Carisma Therapeutics CEO Steven Kelly spoke about his three-pronged mandate to fund the (then) privately held company, build a team, and define a purpose. “Our purpose was to translate the discoveries made [by Michael Klichinsky and Saar Gill] at the ...

Jan 15, 2024 · Last October, the American Association of Pharmaceutical Scientists (AAPS) released its annual salary survey, which measures the earnings of individuals working in pharmaceutical sciences in the U.S., both in academia and industry.I expected the survey to reflect the harsh funding environment, layoffs, and inflation rate that impacted so many people working in the preceding 12 months.